• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts Dermatology

Category Archive

  • Dermatology / May 6, 2021

    A GWAS identifies novel gene associations with facial skin wrinkling and mole count in Latin-Americans.

    View Post
  • Dermatology / March 24, 2021

    Mohs surgery for early-stage Merkel cell carcinoma (MCC) achieves local control better than wide local excision ± radiation therapy with no increase in MCC-specific death.

    View Post
  • Dermatology / April 19, 2021

    Stimulant use in patients presenting with psychocutaneous disorders.

    View Post
  • Dermatology / September 19, 2020

    Symptom burden of atopic dermatitis in early childhood assessed from daily monitoring of symptoms and topical steroid usage.

    View Post
  • Dermatology / December 14, 2020

    Why don’t people with psoriasis take enough exercise?

    View Post

Ulcerative versus non-ulcerative panniculitis: is it time for a novel clinical approach to panniculitis?

In Dermatology
by ClinOwl
October 10, 2020

Panniculitis, or inflammation of the fatty tissue, is an ongoing diagnostic challenge to both dermatologists and pathologists. The basis of the current panniculitis classification is histology, whether the inflammation is …

Eosinophilic folliculitis due to wearing protective gear in citizens volunteering for sanitation services during the COVID-19 pandemic – an original epidemiological, clinical, dermoscopic, and laboratory-based study.

In Dermatology
by ClinOwl
October 10, 2020

An association between wearing protective gear and eosinophilic folliculitis has not been reported. We aimed to investigate such during the COVID-19 pandemic.In three outpatient clinics, we hand-reviewed records of all …

Amelanotic melanoma of the head and neck: analysis of tumor characteristics from the National Cancer Database.

In Dermatology
by ClinOwl
October 10, 2020

Amelanotic melanoma is an extremely rare subtype of cutaneous melanoma. The tumor characteristics are still not well understood, especially for those located in the head and neck.Tumor characteristics of patients …

EFFECTIVENESS OF DUTASTERIDE IN A LARGE SERIES OF PATIENTS WITH FRONTAL FIBROSING ALOPECIA IN REAL CLINICAL PRACTICE.

In Dermatology
by ClinOwl
October 9, 2020

Dutasteride has been proposed as an effective therapy for frontal fibrosing alopecia (FFA).To describe the therapeutic response to dutasteride and the most effective dosage in FFA compared to other therapeutic …

Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study.

In Dermatology
by ClinOwl
October 9, 2020

Dupilumab is an effective treatment for moderate to severe atopic dermatitis (AD) with limited safety data in clinical practice.To assess the 6-month risk of conjunctivitis and serious infections in patients …

Clinical and demographic features of hidradenitis suppurativa: A multicenter study of 1221 patients with an analysis of risk factors associated with disease severity.

In Dermatology
by ClinOwl
October 7, 2020

Hidradenitis suppurativa (HS) is a chronic, relapsing, and debilitating inflammatory disease associated with profound morbidity.In this multicenter study, we investigated the demographic and clinical features of HS and determined risk …

Long-pulsed Nd:YAG laser versus cryotherapy for the treatment of cutaneous warts: a randomized controlled trial.

In Dermatology
by ClinOwl
October 7, 2020

Observational studies have shown promising therapeutic effects of long-pulsed neodymium-doped yttrium aluminum garnet (LP-Nd:YAG) laser on warts.To evaluate whether LP-Nd:YAG laser was superior to cryotherapy for cutaneous warts.In this study, …

Occupation and cutaneous melanoma: a 45-year historical cohort study of 14·9 million people in five Nordic countries.

In Dermatology
by ClinOwl
October 6, 2020

The age-adjusted incidence of cutaneous melanoma (CM) in the Nordic countries has increased during the last 60 years. Few prospective population-based studies have estimated the occupational variation in CM risk over …

Prevalence of antimitochondrial antibodies in subacute cutaneous lupus erythematosus.

In Dermatology
by ClinOwl
October 4, 2020

In approximately 13% of systemic lupus erythematosus (SLE) patients, a hallmark of primary biliary cirrhosis (PBC) can be detected: antimitochondrial M2 antibodies (AMA-M2). It has not been determined if the …

A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman’s formulation in patients with melasma in darker skin.

In Dermatology
by ClinOwl
October 4, 2020

No randomized studies compared the efficacy and safety of modified Kligman’s triple combination (TC) with 1,064 nm Q-switched Nd-YAG laser (QSNYL) in melasma in darker skin.To compare the efficacy and safety …

  • Page 51 of 57
  • ←
  • 1
  • ...
  • 50
  • 51
  • 52
  • ...
  • 57
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer